Personalis stock popped Friday on a rumor Merck and at least two other suitors are trying to buy the small genomics company.
Merck Reportedly Goes To Bat In Takeover Battle. Genomics Stock Flies.
Licensing
09:41 AM ET 07/17/2026
Personalis (PSNL) stock popped Friday on a rumor Merck (MRK) and at least two other suitors are trying to buy the small genomics company. Needham analyst Mike Matson says Tempus AI (TEM) is likely one of the other bidders. Merck, a Dow Jones Industrial Average component, and Tempus AI both own stakes in Personalis. Other large diagnostic companies could also…
The deal expands its portfolio of life sciences tools.
The pharmaceutical giant is a standout performer within the health-care sector, and the stock could be poised for a big jump.
Merck & Co. shares are in focus Monday after a wave of analyst activity capped by a new FDA approval for its cancer drug Keytruda.
Bio-Techne stock jumps, with Germany’s Merck KGaA buying the company at a 24% premium.
Private equity giants circle Qiagen (QGEN) with potential bids of $50/share. Get the details on the molecular diagnostics buyout.
These are the stocks posting the largest moves in early trading.
